Galapagos NV
GLPG
#4692
Rank
S$2.51 B
Marketcap
S$38.10
Share price
-6.58%
Change (1 day)
9.67%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -S$0.7 Billion

According to Galapagos NV's latest financial reports the company's current earnings are S$0.32 Billion. In 2024 the company made an earning of -S$7.39 Million, an increase over its 2023 earnings that were of -S$42.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.7 Billion9267.28%
2024 -S$7.39 Million-82.77%
2023 -S$42.89 Million-85.59%
2022 -S$0.3 Billion60.71%
2021 -S$0.19 Billion-60.08%
2020 -S$0.47 Billion-331.44%
2019 S$0.20 B-523.76%
2018 -S$47.32 Million-72.34%
2017 -S$0.18 Billion-329.59%
2016 S$74.51 M-144.3%
2015 -S$0.17 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.89 B-6,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.82 B-1,690.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$8.43 B-1,339.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.84 B-1,546.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$28.67 B-4,311.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.03 B-2,749.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$12.65 B-1,958.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-S$68.37 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.75 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel